Plasma Protein Therapeutics Market Size Projected To Reach $46.35 Billion By 2034 With A Cagr Of 7.6%

The Plasma Protein Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Plasma Protein Therapeutics Market Size and Projected Growth Rate?
The market size of plasma protein therapeutics has seen substantial growth in the past few years. It is projected to expand from $31.86 billion in 2024 to $34.55 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.5%. Factors contributing to this growth during the historical period include the increasing incidence of rare diseases, an expanding elderly population, an increase in the global blood plasma supply, a rise in hemophilia cases, advancements in diagnostic methods, and a favourable regulatory landscape.

The market size of plasma protein therapeutics is anticipated to considerably expand in the coming years, reaching a value of $46.35 billion in 2029 with a compound annual growth rate (CAGR) of 7.6%. This projected growth within the forecast period can be traced back to the progression in gene therapy, heightened spending on healthcare, broader indications, precision medicine strategies, and patient access initiatives. The forecast period is also expected to be marked by significant trends such as technological breakthroughs, adoption of telemedicine, advancements in plasma fractionation technology, the emergence of next-generation therapies, uptake of recombinant therapies, and personalized medicine approaches.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9213

What Are the Different Plasma Protein Therapeutics Market Segments?
The plasma protein therapeutics market covered in this report is segmented -

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Subsegments:
1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Albumin: Human Serum Albumin, Recombinant Albumin
3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates
4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors
5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

What Are the Primary Drivers Shaping the Plasma Protein Therapeutics Market?
The plasma protein therapeutics market is anticipated to experience growth due to the increasing incidence of autoimmune disorders. Autoimmune disorders arise when the body's immune system mistakenly attacks and destroys its own healthy cells. Therapeutic plasma exchange is applied in the treatment of autoimmune diseases, which occur when the body incorrectly identifies a part of itself as foreign and produces proteins, known as autoantibodies, that attack the part of the body it has wrongly identified. For example, a study undertaken by the University of Glasgow, a public university based in the UK, involving 22 million people in May 2023, discovered that about 10% of UK's population is affected by autoimmune disorders, a figure that surpasses previous estimations. As a result, the growing incidence of autoimmune disorders is fuelling the expansion of the plasma protein therapeutics market.

Which Companies Are Leading in the Plasma Protein Therapeutics Market?
Major companies operating in the plasma protein therapeutics market include CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., New York Blood Center, Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Australian Red Cross Lifeblood

What Are the Major Trends Shaping the Plasma Protein Therapeutics Market?
The emergence of product innovations is a prevalent trend being witnessed in the plasma protein therapeutic market. Most enterprises in this sector are shifting their focus on creating innovative products to establish a competitive edge in the industry. For instance, Octapharma AG, a company from Switzerland, was granted approval by the European medical authorities in October 2023 for the lyophilized version of their popular product, octaplasLG. This modern formulation is crafted for pre-hospital transfusion, granting healthcare professionals with a practical and efficient solution for handling patients in critical conditions. The approval marks Octapharma's dedication to improving patient care through inventive strategies in the area of blood products.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

What Are the Top Revenue-Generating Geographies in the Plasma Protein Therapeutics Market?
North America was the largest region in the plasma protein therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Plasma Protein Therapeutics Market?
2. What is the CAGR expected in the Plasma Protein Therapeutics Market?
3. What Are the Key Innovations Transforming the Plasma Protein Therapeutics Industry?
4. Which Region Is Leading the Plasma Protein Therapeutics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.